Circular RNA hsa_circRNA_101996 modulates gastric cancer cell proliferation and apoptosis through the miR-577/HMGN5

Xiao-Lei Wang1, Lin Zhang2, Qing Shang3

  • 1Department of General Surgery, Xinxiang Central Hospital, Xinxiang 453000, Henan Province, China. wangxl305@163.com.

Abstract

Insights

Circular RNAs (circRNAs) promote gastric cancer by upregulating HMGN5 via sponging miR-577. This study identifies hsa_circRNA_101996 as a potential therapeutic target for gastric cancer treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Circular RNAs (circRNAs) are key regulators in cancer development.
  • While many circRNAs are linked to gastric cancer, the function of hsa_circRNA_101996 is not well understood.
  • This study investigates hsa_circRNA_101996's role in gastric cancer.

Purpose of the Study:

  • To determine the role of hsa_circRNA_101996 in gastric cancer cell proliferation and apoptosis.
  • To elucidate the mechanism involving microRNA-577 (miR-577) and high mobility group nucleosome binding domain 5 (HMGN5).

Main Methods:

  • Analysis of 41 paired gastric cancer tissues and adjacent non-cancerous tissues.
  • Utilized bioinformatics datasets (GSE83521, GSE89143) for differential circRNA expression analysis.
  • Performed in vitro experiments (MTT, colony formation, Western blot, dual-luciferase reporter assays) and in vivo tumorigenesis studies in nude mice.

Main Results:

  • Hsa_circRNA_101996 was significantly upregulated in gastric cancer tissues and cell lines.
  • Validated interactions between hsa_circRNA_101996, miR-577, and HMGN5.
  • Overexpression of hsa_circRNA_101996 increased proliferation and decreased apoptosis in vitro, while miR-577 mimics had opposite effects. In vivo studies confirmed increased tumor volume and HMGN5 expression.

Conclusions:

  • Hsa_circRNA_101996 promotes gastric cancer progression by acting as a sponge for miR-577, leading to increased HMGN5 expression.
  • This circRNA-miRNA-mRNA axis represents a potential novel therapeutic target for gastric cancer.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.0K